Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. (TRDA) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 347 transactions totaling $50.8M, demonstrating a bullish sentiment with $27.8M in net insider flow. The most recent transaction on Nov 21, 2025 involved a sale of 8,910 shares valued at $88.9K.
TRDA Insider Activity Summary
Who Is Buying TRDA Stock?
No significant insider buying has been recorded for TRDA in the recent period.
Who Is Selling TRDA Stock?
No significant insider selling has been recorded for TRDA in the recent period.
Is Entrada Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TRDA is bullish with an Insider Alignment Score of 77/100 and a net flow of $27.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TRDA Frequently Asked Questions
Understanding TRDA Insider Activity
Insider trading at Entrada Therapeutics, Inc. (TRDA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading TRDA stock, having executed 347 transactions in the past 90 days. The most active insider is Group, Llc Redmile (Executive), who has made 2 transactions totaling $20.0M.
Related Tools
Track Entrada Therapeutics, Inc. Insider Activity
Get notified when executives and directors at TRDA file new Form 4 transactions